Yael L. Maxwell

TCTMD celebrates its 25th anniversary! Listen to the editorial team reflect on the website's greatest hits over the years. www.tctmd.com/audio/tctmd-...
@yaelmaxwell.bsky.social
@lamckeown1.bsky.social

Education Meets TikTok: Cardiac Surgeons Teach Patient Recovery in New Ways Doctors might feel out of their element making the videos, but patients respond to the short, informative reels.

"I felt crazy as a senior cardiac surgeon making TikTok videos," said Dan Engelman at #EACTS2025. "But it turns out that’s what people watch. . . . And they want the message in one minute, it turns out, or less." #CardioSky

www.tctmd.com/news/educati...

Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last Data from implantable monitors show a low AF burden with time, leading some to question the need for oral anticoagulation.

"Given the known bleeding risk with oral anticoagulants, the very low AF burden questions current ESC guidelines recommending long-term oral anticoagulation," said Florian Herrmann. #EACTS2025 #CardioSky

www.tctmd.com/news/nearly-...

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data The findings sparked a debate about the merits of RCTs vs other study designs—one surgeon urged others to “read a textbook.”

My first story from #EACTS2025 dives into a unique analysis comparing 5-year TAVI vs SAVR mortality that provoked some strong feelings about what type of research should inform guidelines. #CardioSky
www.tctmd.com/news/savr-be...

Looking forward to being at #EACTS2025. Full coverage to come on @tctmd.bsky.social

“The time-sensitive nature of transthyretin cardiomyopathy is something that has been on many people’s minds, but I think this is the first piece of evidence that should push us forward,” said Ahmad Masri, MD at #HFSA2025. #CardioSky

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI The drug met primary safety and efficacy outcomes, with full results to be presented at the AHA Scientific Sessions.

In the phase III CELEBRATE trial, the novel injectable glycoprotein IIb/IIIa inhibitor zalunfiban has met its primary safety and efficacy outcomes in STEMI patients. Read more here: www.tctmd.com/news/celebra...

“You often learn from when science goes the opposite direction from what you expect,” said presenter David Berg, MD. The next question to answer is what role GDF-15 plays in heart failure. #HFSA2025 #CardioSky

Another from #HFSA2025: this time looking at a new CCM-D device in patients with HFrEF. Will this be enough for CCM to gain traction in the HF world? #CardioSky

My first from #HFSA2025 and an interesting one to boot! The Cordio HearO App can pick up signals of heart failure events more than 3 weeks before they happen. #CardioSky

The first plenary session at #HFSA2025 is about to begin and all of my coverage will be on ⁦‪@tctmd.bsky.social!‬⁩ Who else is here and what are you looking forward to at the meeting?

What's new in the world of cardiology? In this month's Heart Sounds, the TCTMD team highlights their favorite stories from September, and @DrRobRoswell joins to discuss DAPT-SHOCK-AMI. Full episode here: www.tctmd.com/audio/top-ca...

@yaelmaxwell.bsky.social

ESC/EACTS Release New Valvular Heart Disease Guidelines Among the changes are a lower TAVI age cutoff and greater emphasis on patient education and coronary CTA.

Earlier, less invasive treatment is the name of the game according to new @escardio.bsky.social and @eacts.bsky.social valvular heart disease guidelines. #ESCongress

www.tctmd.com/news/esceact...

On the latest On Record, @yaelmaxwell.bsky.social, Gilbert Tang, and Tsuyoshi Kaneko discuss reinterventions after TAVI during #NYValves2025. Watch the full video here: www.tctmd.com/videos/on-re...

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists The document, last updated in 2017, promotes use of the PREVENT calculator as well as more flexible BP goals.

New US hypertension guidelines, the first since 2017, released today reinforce prior recs that prioritize lowering BP early and aggressively, with special emphasis on lifestyle, the connection between BP and cognitive function, and pregnancy. #CardioSky

www.tctmd.com/news/new-acc...

During #NYValves2025, Patrick O'Gara, Michael Borger, and @yaelmaxwell.bsky.social discussed how the FDA approval of asymptomatic TAVI has changed practice, with perspectives from the US and Europe. Watch the full episode of On Record here: www.tctmd.com/videos/on-re...

In this episode of Heart Sounds, our TCTMD journalists discuss the top news in cardiology for July. @lamckeown1.bsky.social @yaelmaxwell.bsky.social @toddneale.bsky.social www.tctmd.com/audio/top-ca...

I set up a Signal account if anyone would prefer to reach me there.

Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists The decade-long, single-healthcare-system study gives insights into how physicians are using CAC tests and in which patients.

Whether a patient undergoes CAC screening depends on the type of doctor they see, with large sex differences observed over the past decade at a single healthcare system, according to retrospective data. #SCCT2025 #CardioSky

www.tctmd.com/news/cardiol...

Less Plaque With Intensive Medical Therapy vs Usual Care in INOCA: WARRIOR The serial imaging substudy shows that intensive therapy might change plaque morphology positively, researchers say.

Intensive medical therapy usual care for reducing noncalcified coronary plaque in women who have INOCA, according to results of a serial imaging subanalysis of the WARRIOR trial. #SCCT2025 #CardioSky @damini-d.bsky.social

www.tctmd.com/news/less-pl...

Defining Success in Medicine From patient satisfaction to making family and mentors proud, fellows tell TCTMD they feel fulfilled in a variety of ways.

New in the @tctmd.bsky.social Fellows in Focus Feed: Attendees at #Fellows2025 tell us how they define success in medicine. #FellowsForum #CardioSKy

www.tctmd.com/videos/defin... @abdullahalabcha.bsky.social

Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges A special session at SCCT was dedicated to the history of the field, but also explored future directions and unanswered questions.

Leaders in the field of cardiac CT celebrated 20 years of science, innovation, and overcoming challenges during a special session at the 2025 @scct-heart.bsky.social meeting. #SCCT2025 #CardioSky

www.tctmd.com/news/leaders...

AI-QCT Possibly Lessens Gap Between Ideal vs Actual Care for Patients at Risk of ASCVD The “hypothesis-generating” results show that the technology might improve use of preventive therapies, especially in women.

AI-QCT can potentially improve preventive care for patients, especially women, thought to be at risk for ASCVD, according to an analysis of the CERTAIN study. #SCCT2025 #CardioSky

www.tctmd.com/news/ai-qct-...

AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.

For symptomatic patients who’ve undergone CCTA, added knowledge gleaned from AI-CPA (@heartflow.bsky.social) changes the management strategy more than half the time, according to new data from the DECIDE registry.

tctmd.com/news/ai-base...
@cianpmccarthy.bsky.social #SCCT2025 #Cardiosky

Adding Coronary CT Angiography to Annual Firefighter Physicals Could Save Lives Scanning identified significant CAD in this high-risk population, even among those with zero CAC.

Among more than 300 young, fit firefighters, CCTA led to 3.6% undergoing a diagnostic cath and 28.6% being referred to a cardiologist for medical or lifestyle management. Among the 2/3 with 0 CAC, 83% had noncalcified plaque. #SCCT2025 #CardioSky

www.tctmd.com/news/adding-...

I’m excited to be in Montréal for #scct2025. Who else is here and what are you most looking forward to hearing about? (And where can I find the best poutine in town?😉)

Carbon Footprint of Surgical AVR Double the Size of TAVI’s The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

"It’s not so much that one therapy is better than another, but there are consequences to everything that we do," says Isaac George.

www.tctmd.com/news/carbon-... #cardiosky

Carbon Footprint of Surgical AVR Double the Size of TAVI’s The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

"It’s not so much that one therapy is better than another, but there are consequences to everything that we do," says Isaac George.

www.tctmd.com/news/carbon-... #CardioSky

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.

TEER with the Pascal system in patients with degenerative MR results in good early survival outcomes, significant reductions in MR, and improvements in quality of life, according to an analysis of the STS/ACC TVT Registry. #NYValves2025 #CardioSky

www.tctmd.com/news/good-ou...

Long-term Survival Better With TAVI Explant vs Redo: Medicare Data The procedures are not mutually exclusive, however, and should be considered on a patient-by-patient basis, a researcher says.

My 1st from #NYValves2025 (and my 1st time at this meeting!):

Surgical explant is associated with better long-term survival compared with redo TAVI in a population of Medicare patients requiring reintervention. @ShinFukuharaMD @DrBowdish @TsuyoshiKaneko1

www.tctmd.com/news/long-te...